This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML-powered solutions are revolutionising healthcare by enabling accurate diagnosis, personalised treatment plans, and efficient drug discovery.
Herding a patient’s data from many sources into a single record has always been a lofty goal of digital health. According to an excellent whitepaper describing a case study of Medrec , a platform utilizing blockchain technology, healthinformation interoperability is facilitated with the use of blockchain.
Several key trends and predictions are emerging: Increased focus on digital health and AI: AI-powered diagnostics and drug discovery: Companies specialising in AI-driven medical imaging, genomics analysis, and drugdevelopment are likely to attract significant interest from larger pharmaceutical and technology firms.
Read more… One HIE’s Approach to Identity Management. John spoke to Dan Chavez of the Santa Cruz HealthInformation Organization about why including SDoH data makes patient identity more challenging but also more valuable to the clinicians and patients that SCHIO serves.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Drug Development 
61 
Let's personalize your content